Anatabine(CAS: 581-49-7)

Anatabine (CAS: 581-49-7) falls under regulatory guidelines such as GHS classification for hazardous substances, REACH regulations for assessing, managing, and authorizing the marketing and use of chemical substances in the European Union, and FDA/EPA requirements for safe handling and disposal. Specific guidelines may vary based on the intended use and geographical location.

Alternatives to Anatabine (CAS: 581-49-7) include similar alkaloids like anatoleptine and anatabine analogs such as N-allyl anatabine. Isomers and other reagents, such as 3-(4-hydroxyphenyl)propylamine, can also be used as substitutes. These alternatives may vary in efficacy and synthesis complexity.

The market for Anatabine (CAS: 581-49-7) is growing due to its potential applications in pharmaceuticals, agriculture, and research. Recent trends indicate increased interest in its biological activities, such as anti-inflammatory and antispasmodic effects, leading to more studies and commercial development. Market trends also reflect evolving regulations and increasing demand in international markets.

Waste containing Anatabine (CAS: 581-49-7) should be collected and stored in sealed containers to prevent leaks or spills. Proper incineration or professional waste disposal services should be utilized to ensure safe disposal. Environmental protection precautions include minimizing exposure to water sources and ensuring compliance with local and national waste management regulations.